Country | : Belgium ![]() |
Sector | : Pharma / Smaller Pharma |
Market Cap | : 16,136 (M€) |
Score (0-10) | Sector avg | Ranking out of 544 | |||
---|---|---|---|---|---|
Sustainability | 6.4 | 5.2 | 117 | ||
Our approach is based on analytical items contributing to the E, the S and the G, that can be highlighted as sustainability precursors and can be combined in an intellectually acceptable way. | |||||
Governance | 7.2 | 5.7 | 190 | ||
Board independence? | Yes | ||||
Splitting CEO and chairman roles? | No | ||||
+10 other Governance metrics | |||||
Social | 7.3 | 6.3 | 91 | ||
Are accident at work declining? | Yes | ||||
Wage dispersion trend vs peers | 3 / 10 | ||||
+22 other Social metrics | |||||
Environment | 8.6 | 6.5 | 48 | ||
Emission or consumption per € of capital employed on :
► Energy ► CO2 emissions ► Waste ► Water withdrawal |
|||||
ESG impact on target price | 2.2% |
0.1% | 93 |
Company | Sustainability | Ranking |
---|---|---|
![]() |
3.7 | 479 |
![]() |
4.5 | 385 |
![]() |
6.4 | 121 |
![]() |
5.3 | 277 |
![]() |
5.1 | 312 |
![]() |
3.3 | 506 |
![]() |
6.4 | 117 |
![]() |
6.9 | 64 |
Learn more on our methodology : | |
Access for issuers : | |
To AlphaValue research platform: |